ATHA Stock Predictions
| Recent ATHA Stock Price | ATHA Stock Predictions | |
| $2.06 |  +302.91% |
$8.30 |
| Recent ATHA Analyst Ratings Breakdown, Making ATHA Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 3 | 3 | 3 | 3 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 2 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.8 | 1.8 | 1.8 | 1.8 |
For the ATHA stock predictions from the analysts covering Athira Pharma Inc, we have collected all of the individual ATHA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering ATHA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ATHA stock predictions may vary widely, another useful metric to consider is the median ATHA stock prediction, which represents the price at which half of the analysts
made ATHA stock predictions that were higher and half made ATHA stock predictions that were lower. This makes for a different take on the ATHA stock predictions out there, as compared to average or mean.
And that median across all the individual ATHA stock predictions was: $5.0 as of 2024-04-19.
The very highest of the ATHA stock predictions for one year price target was $19.0, while the very lowest of the ATHA stock predictions in the analyst group was
$3.5 (with a standard deviation of $6.515). Get the latest Zacks research report on ATHA — FREE
Find out: ATHA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• KALA Stock Predictions
• CLVS Stock Predictions
• ARAY Stock Predictions
• SIGI Stock Predictions
• BBDC Stock Predictions
• HAFC Stock Predictions
• OHI Stock Predictions
• EL Stock Predictions
• QGEN Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
 
|
Buy (3.20 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
